Rapid Spread of the SARS-CoV-2 Variant of Concern 202012/01 in Southern Italy (December 2020–March 2021)
Abstract
:1. Introduction
2. Materials and Methods
2.1. Epidemiological Surveillance
2.2. Molecular Test for SARS-CoV-2 Infection and Whole-Genome Sequencing
2.3. Data Analysis
2.4. Ethical Statement
3. Results
Sequence Analyses
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Wise, J. Covid-19: New coronavirus variant is identified in UK. BMJ (Clinical Research ed.) 2020, 371, m4857. [Google Scholar] [CrossRef]
- European Center for Disease Prevention and Control. Risk Assessment: Risk Related to Spread of New SARS-CoV-2 Variants of Concern in the EU/EEA. 29 December 2020. Available online: https://www.ecdc.europa.eu/en/publications-data/covid-19-risk-assessment-spread-new-sars-cov-2-variants-eueea (accessed on 12 March 2021).
- European Center for Disease Prevention and Control. Risk Assessment: Risk Related to the Spread of New SARS-CoV-2 Variants of Concern in the EU/EEA—First Update. 21 January 2021. Available online: https://www.ecdc.europa.eu/en/publications-data/covid-19-risk-assessment-spread-new-variants-concern-eueea-first-update (accessed on 12 March 2021).
- European Center for Disease Prevention and Control. Risk Assessment: SARS-CoV-2—Increased Circulation of Variants of Concern and Vaccine Rollout in the EU/EEA, 14th Update, Risk Assessment 15 February 2021. Available online: https://www.ecdc.europa.eu/en/publications-data/covid-19-risk-assessment-variants-vaccine-fourteenth-update-february-2021 (accessed on 12 March 2021).
- European Center for Disease Prevention and Control. Rapid Increase of a SARS-CoV-2 Variant with Multiple Spike Protein Mutations Observed in the United Kingdom. Threat Assessment Brief. 20 December 2020. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/SARS-CoV-2-variant-multiple-spike-protein-mutations-United-Kingdom.pdf (accessed on 12 March 2021).
- Davies, N.G.; Jarvis, C.I.; CMMID COVID-19 Working Group; Edmunds, W.J.; Jewell, N.P.; Diaz-Ordaz, K.; Keogh, R.H. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature 2021. [Google Scholar] [CrossRef] [PubMed]
- Istituto Superiore di Sanità (ISS). Prevalenza Delle Varianti VOC 202012/01 (Lineage B.1.1.7), P.1, e 501.V2 (Lineage B.1.351) in Italia Indagine del 18 Febbraio 2021. Available online: https://www.iss.it/documents/20126/0/Relazione+tecnica+terza+indagine+flash+per+le+varianti+del+virus+SARS-CoV-2+%282%29.pdf?fbclid=IwAR2yoTbzwM-fU8K2KIwpM4Gnk76qTHD4zihFwEf8zYF1nwsG8T0tNpRlVIo (accessed on 3 March 2021).
- Istituto Superiore di Sanità (ISS). Prevalenza Delle Varianti VOC (Variant of Concern) in Italia: Lineage B.1.1.7, P.1, P.2, Lineage B.1.351, Lineage B.1.525. Available online: https://www.iss.it/documents/20126/0/Rapporto+indagine+varianti+SARS-CoV-2.pdf/3ba8d61d-eeb2-4db2-c33f-250226fa73a7?t=1617119597042 (accessed on 26 April 2021).
- Rambaut, A. Preliminary Genomic Characterisation of an Emergent SARS-CoV-2 Lineage in the UK Defined by a Novel Set of Spike Mutations—SARS-CoV-2 Coronavirus/nCoV-2019 Genomic Epidemiology, Virological: 2020. Available online: https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563 (accessed on 30 January 2021).
- Challen, R.; Brooks-Pollock, E.; Read, J.M.; Dyson, L.; Tsaneva-Atanasova, K.; Danon, L. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: Matched cohort study. BMJ (Clinical Research ed.) 2021, 372, n579. [Google Scholar] [CrossRef]
- Munitz, A.; Yechezkel, M.; Dickstein, Y.; Yamin, D.; Gerlic, M. BNT162b2 Vaccination Effectively Prevents the Rapid Rise of SARS-CoV-2 Variant B.1.1.7 in high risk populations in Israel. Cell Rep. Med. 2021, 100264. [Google Scholar] [CrossRef] [PubMed]
- Borges, V.; Sousa, C.; Menezes, L.; Gonçalves, A.M.; Picão, M.; Almeida, J.P.; Vieita, M.; Santos, R.; Silva, A.R.; Costa, M.; et al. Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: Insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021, Bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. Eurosurveillance 2021, 26, 2100131. [Google Scholar] [CrossRef]
- Investigation of Novel SARS-CoV-2 Variant: Variant of Concern 2020/12/01—Technical Briefing 7. Available online: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/968581/Variants_of_Concern_VOC_Technical_Briefing_7_England.pdf (accessed on 15 March 2021).
- Loconsole, D.; Sallustio, A.; Accogli, M.; Centrone, F.; Capozzi, L.; Del Sambro, L.; Parisi, A.; Chironna, M. Genome Sequence of a SARS-CoV-2 VUI 202012/01 Strain Identified from a Patient Returning from London, England, to the Apulia Region of Italy. Microbiol. Resour. Announc. 2021, 10, e01487-20. [Google Scholar] [CrossRef] [PubMed]
- Istituto Superiore di Sanità. Sorveglianza COVID-19. Available online: https://covid-19.iss.it/login.aspx?ReturnUrl=%2f (accessed on 29 April 2021).
- Ministero della Salute. Covid-19—Situazione in Italia. Available online: http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioContenutiNuovoCoronavirus.jsp?area=nuovoCoronavirus&id=5351&lingua=italiano&menu=vuoto (accessed on 23 March 2021).
- Regione Puglia. Sistema Informativo Regionale GIAVA COVID-19 per la Gestione Dell’Emergenza Sanitaria. Available online: https://covid19.sanita.puglia.it/#/login (accessed on 29 April 2021).
- AIFA: Sospensione Precauzionale Del Vaccino AstraZeneca. 15 Marzo 2021. Available online: https://www.aifa.gov.it/documents/20142/1289678/Comunicato_AIFA_637.pdf/81dafc37-42a1-dbbf-b607-25123fbe31f4 (accessed on 23 March 2021).
- AIFA Revoca Divieto d’Uso Vaccino AstraZeneca. 19 Marzo 2021. Available online: https://www.aifa.gov.it/-/aifa-revoca-il-divieto-d-uso-riprendono-dalle-15-le-vaccinazioni-con-astrazeneca (accessed on 23 March 2021).
- Priesemann, V.; Balling, R.; Brinkmann, M.M.; Ciesek, S.; Czypionka, T.; Eckerle, I.; Giordano, G.; Hanson, C.; Hel, Z.; Hotulainen, P.; et al. An action plan for pan-European defence against new SARS-CoV-2 variants. Lancet 2021, 397, 469–470. [Google Scholar] [CrossRef]
Characteristics | SGTF-Positive | SGTF-Negative | p-Value |
---|---|---|---|
Sex | |||
Male | 313 (50.4%) | 1156 (47.2%) | 0.14 |
Female | 308 (49.6%) | 1298 (53.0%) | 0.14 |
Age groups (%) | |||
0–4 yrs | 21 (3.38%) | 70 (2.85%) | 0.57 |
5–16 yrs | 75 (12.08%) | 268 (10.92%) | 0.45 |
17–35 yrs | 144 (23.19%) | 670 (27.30%) | 0.04 |
36–65 yrs | 272 (43.80%) | 1048 (42.71%) | 0.65 |
>65 yrs | 109 (17.55%) | 398 (16.22%) | 0.45 |
Symptomatic infection | 321 (51.7%) | 963 (39.3%) | <0.0001 |
Mild | 214 (66.7%) | 625 (64.9%) | 0.61 |
Moderate | 86 (26.8%) | 289 (30.0%) | 0.30 |
Severe | 21 (6.5%) | 49 (5.1%) | 0.39 |
Asymptomatic infection | 300 (48.3%) | 1491 (60.7%) | <0.0001 |
Hospitalization | 35 (5.6%) | 69 (2.8%) | <0.0001 |
Death | 4 (0.6%) | 23 (0.9%) | 0.64 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Loconsole, D.; Centrone, F.; Morcavallo, C.; Campanella, S.; Sallustio, A.; Accogli, M.; Fortunato, F.; Parisi, A.; Chironna, M. Rapid Spread of the SARS-CoV-2 Variant of Concern 202012/01 in Southern Italy (December 2020–March 2021). Int. J. Environ. Res. Public Health 2021, 18, 4766. https://doi.org/10.3390/ijerph18094766
Loconsole D, Centrone F, Morcavallo C, Campanella S, Sallustio A, Accogli M, Fortunato F, Parisi A, Chironna M. Rapid Spread of the SARS-CoV-2 Variant of Concern 202012/01 in Southern Italy (December 2020–March 2021). International Journal of Environmental Research and Public Health. 2021; 18(9):4766. https://doi.org/10.3390/ijerph18094766
Chicago/Turabian StyleLoconsole, Daniela, Francesca Centrone, Caterina Morcavallo, Silvia Campanella, Anna Sallustio, Marisa Accogli, Francesca Fortunato, Antonio Parisi, and Maria Chironna. 2021. "Rapid Spread of the SARS-CoV-2 Variant of Concern 202012/01 in Southern Italy (December 2020–March 2021)" International Journal of Environmental Research and Public Health 18, no. 9: 4766. https://doi.org/10.3390/ijerph18094766